Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety
@article{Lattanzi2019ErenumabFP, title={Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety}, author={S. Lattanzi and Francesco Brigo and E. Trinka and F. Vernieri and Tommaso Corradetti and M. Dobran and M. Silvestrini}, journal={Drugs}, year={2019}, volume={79}, pages={417-431} }
BackgroundNovel therapeutic options with improved efficacy and safety profiles are needed for the prophylaxis of migraine. In recent years, the inhibition of calcitonin gene-related peptide (CGRP) signaling has attracted growing interest in the pharmacological research on migraine. Erenumab is the first fully human monoclonal antibody directed against the CGRP receptor to be approved for use in migraineurs.ObjectiveTo evaluate the efficacy and safety of erenumab as preventive treatment in… CONTINUE READING
Figures, Tables, and Topics from this paper
24 Citations
The role of erenumab in the treatment of migraine
- Medicine
- Therapeutic advances in neurological disorders
- 2020
- 2
Safety and Efficacy of Ubrogepant for the Acute Treatment of Episodic Migraine: A Meta-Analysis of Randomized Clinical Trials
- Medicine
- CNS Drugs
- 2020
- 3
Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – an updated systematic review and meta-analysis
- Medicine
- BMC Neurology
- 2020
- 9
Levetiracetam as preventive treatment in adults with migraine: an up-to-date systematic review and quantitative meta-analysis
- Medicine
- European Journal of Clinical Pharmacology
- 2019
Lasmiditan for Acute Treatment of Migraine in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- Medicine
- CNS Drugs
- 2020
- 1
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
- Medicine
- The Journal of Headache and Pain
- 2020
- 10
Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece
- Medicine
- Clinical Drug Investigation
- 2019
- 4
References
SHOWING 1-10 OF 57 REFERENCES
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- Medicine
- The Lancet Neurology
- 2017
- 260
- Highly Influential
- PDF
The efficacy and safety of calcitonin gene-related peptide monoclonal antibody for episodic migraine: a meta-analysis
- Medicine
- Neurological Sciences
- 2018
- 21
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- Medicine
- Cephalalgia : an international journal of headache
- 2018
- 160
- Highly Influential
- PDF
Early onset of efficacy with erenumab in patients with episodic and chronic migraine
- Medicine
- The Journal of Headache and Pain
- 2018
- 26
A Controlled Trial of Erenumab for Episodic Migraine
- Medicine
- The New England journal of medicine
- 2017
- 317
- Highly Influential
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
- Medicine
- The Lancet Neurology
- 2016
- 192
- Highly Influential
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab
- Medicine
- Cephalalgia : an international journal of headache
- 2018
- 24
Topiramate in migraine prevention: results of a large controlled trial.
- Medicine
- Archives of neurology
- 2004
- 485
- PDF
Drug safety and tolerability in prophylactic migraine treatment
- Medicine
- Expert opinion on drug safety
- 2015
- 28
- PDF